Hypercholesterolemia modifies angiotensin II desensitisation and cross talk between α1-adrenoceptor and angiotensin AT1 receptor in rabbit aorta

European Journal of Pharmacology

Volumn 635, Issue 1-3, 2010, Pages 149-155

  Jerez, Susana ^a   Sierra, Liliana ^a   Scacchi, Fabricio ^a   de Bruno, María Peral ^b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Universidad Nacional de Tucuman UNT Facultad de Medicina   (Argentina)

Author keywords

1 adrenoceptor; Angiotensin AT1 receptor; Angiotensin II; Cross talk; Endothelial dysfunction; Noradrenaline

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CHOLESTEROL; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; HYPERPOLARIZATION; LIPID DIET; MALE; MOLECULAR INTERACTION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RABBIT; REST; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; THORACIC AORTA; VASCULAR RING;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; DIETARY FATS; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH; NOREPINEPHRINE; RABBITS; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADRENERGIC, ALPHA-1; REST; VASOCONSTRICTION;

EID: 77952320144     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.043     Document Type: Article

References (26)

1. AbdAlla S., Lother H., Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 2000, 407:94-98.
2. Barki-Harrington L., Luttrell L.M., Rockman H.A. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 2003, 108:1611-1618.
3. Chen M., Mason R.P., Tulenko T.N. Atherosclerosis alters the composition, structure and function of arterial smooth muscle cell plasma membranes. Biochim. Biophys. Acta 1995, 1272:101-112.
4. 1-adrenergic receptors in cardiomyopathic hamsters. J. Card. Fail. 2000, 6:257-263.
5. Du Y., Qiu J., Nelson S.H., Wang D.H. Regulation of type 1 angiotensin II receptor in vascular tissue: role of alpha1-adrenoceptor. Am. J. Physiol. 1997, 273:R1224-R1229.
6. Franco R., Casadó V., Cortés A., Mallol J., Ciruela F., Ferré S., Lluis C., Canela E.I. G-protein-coupled receptors heteromers: function and ligand pharmacology. Br. J. Pharmacol. 2008, 153:S90-S98.
7. Gillies P., Robinson C. Decreased plasma membrane fluidity in the development of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1988, 70:161-164.
8. Gruetter C.A., Ryan E.T., Schoepp D.D. Endothelium enhances tachypyhlaxis to angiotensin II and III in rat aorta. Eur. J. Pharmacol. 1987, 143:139-142.
9. Gurwitz D. Receptor cross talk: a surprising twist on an old concept. Mol. Med. Today 2000, 6:261.
10. Hu Z.W., Shi X.Y., Okazaki M., Hoffman B.B. angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am. J. Physiol. 1995, 268:H1006-H1014.
11. Jerez S., Peral de Bruno M., Coviello A. Endothelium dependent desensitisation to angiotensin II in rabbit aorta: mechanisms involved. Can. J. Physiol. Pharmacol. 2001, 79:481-489.
12. Jerez S., Peral de Bruno M., Coviello A. Cross-talk between angiotensin II and alpha 1 adrenergic receptors in rabbit aorta: role of endothelium. J. Cardiovas. Pharmacol. 2004, 43:402-409.
13. Jerez S., Sierra L., Coviello A., Peral de Bruno M. Endothelial dysfunction and improvement of the angiotensin II reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites. Eur. J. Pharmacol. 2008, 580:182-189.
14. Karip E., Turu G., Süpeki K., Szindonya L., Hynyady H. Cross-inhibition of Angitoensin AT1 receptors supports the concept of receptor oligomerization. Neurochem. Int. 2007, 51:261-267.
15. Kienecker E.W., Knoche H. Sympathetic innervation of the pulmonary artery, ascending aorta, and coronar glomera of the rabbit. Cell Tissue Res. 1978, 188:329-333.
16. Kuttan S.C., Sim M.K. angiotensin II-induced tachyphylaxis in aortas of normo- and hypertensive rats: changes in receptor affinity. Eur. J. Pharmacol. 1993, 232:173-180.
17. 1-adrenergic receptors. Circ. Res. 1997, 81:396-403.
18. Maeso R., Navarro-Cid J., Muñoz-Garcia R., Rodrigo E., Ruilope L.M., Lahera V., Cachofeiro V. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Hypertension 1996, 28:967-972.
19. Oro C., Qian H., Tomas W.G. Type 1 angiotensin receptor pharmacology: signaling beyond G-proteins. Pharmacol. Ther. 2007, 113:110-226.
20. Prinster S.C., Hague C., Hall R.A. Heterodimerization of G-protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 2005, 57:289-298.
21. Silva E.G., Ferreira A.T., Paiva A.C.M., Paiva T.B. Angiotensin tachyphylaxis in normal and everted rings of rabbit aorta. Eur. J. Pharmacol 1988, 153:185-190.
22. Sorensen K.E., Celermajer D.S., Georgakoòulos D., Hatcher G., Betteridge D.J., Deanfield J.E. Impairment of endothelium dependent vasodilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J. Clin. Invest. 1994, 93:50-55.
23. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol. Sci. 1991, 12:55-62.
24. Verbeuren T.J., Jordens F.H., Zonnekeyn L.L., VanHove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in rabbit. Circ. Res. 1986, 58:552-564.
25. Villalobos-Molina R., Ibarra M. Increased expression and function of vascular alpha1 D-adrenoceptors may mediate the prohypertensive effects of angiotensin II. Mol. Interv. 2005, 5:340-342.
26. Yang H., Lu D., Raizada M.K. Lack of cross talk between alpha1-adrenergic and angiotensin type 1 receptors in neurons of spontaneously hypertensive rat brain. Hypertension 1996, 27:1277-1283.